Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Oct. 02, 2011	Oct. 03, 2010
Operating activities:
Net income	$ 333,277	$ 53,373
Adjustments:
Depreciation and amortization	145,843	200,718
Stock-based compensation expense	38,480	51,884
Non-cash restructuring of operations and other items, net	30,535	(41)
Write-down of investments, net of gain on sale		6,779
Gain on sale of business	(260,066)
(Gain)/loss on sale of property and equipment	(543)	153
Unrealized foreign exchange loss	200	6,374
Deferred taxes	(18,944)	34
Changes in assets and liabilities:
Accounts receivable, net	78,215	25,094
Inventories	(60,203)	(50,785)
Prepaid expenses, assets held for sale and other assets	(10,256)	13,898
Accounts payable	(1,700)	(23,541)
Accrued and other liabilities	(83,479)	(28,405)
Net cash provided by operating activities	191,359	255,535
Investing activities:
Purchases of debt securities available-for-sale	(38,683)	(24,218)
Proceeds from maturities and sales of debt securities available-for-sale	31,988	36,209
Purchases of other investments	(4,000)	(316)
Proceeds from sale of other investments		9,795
Purchases of property and equipment	(46,841)	(67,262)
Proceeds from sale of property and equipment	939	559
Proceeds from sale of business, net of transaction costs	475,150
Net cash provided by/(used in) investing activities	418,553	(45,233)
Financing activities:
Redemption of convertible subordinated notes		(349,999)
Issuances of common stock	66,060	22,057
Purchase of common stock under repurchase programs	(471,787)	(217,743)
Net cash used in financing activities	(405,727)	(545,685)
Effect of exchange rate changes on cash and cash equivalents	(821)	(3,927)
Net change in cash and cash equivalents	203,364	(339,310)
Cash and cash equivalents at beginning of period	521,786	778,291
Cash and cash equivalents at end of period	$ 725,150	$ 438,981